Light-Activated Silicon Nanostructures for Non-Invasive Cellular Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing implantable devices for treating diseases through optical stimulation face challenges such as bulkiness, mechanical invasiveness, and the need for genetic modifications, lacking sub-cellular specificity and ease of administration.
Innovation Solution
The use of silicon nanostructures to modulate cellular activity through light exposure, forming a structure-cell membrane interface that mimics natural extracellular signals, allowing for non-invasive, genetically non-modifying cellular modulation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If implantable devices are used for optical stimulation, then disease treatment efficacy is improved, but device bulkiness and mechanical invasiveness increase
Solution Approach 1:
The patent replaces mechanical implantable devices with photonic nanoparticles that can be administered systemically. These nanoparticles contain photostimulatory compounds that convert light energy into biological effects, substituting mechanical stimulation with optical stimulation at the cellular level. This eliminates the need for surgical implantation while maintaining therapeutic efficacy.
Solution Approach 2:
The patent changes the scale and physical state of the stimulatory device from macroscopic implantable structures to nanoscale particles that can circulate in the bloodstream. This parameter change from millimeter-scale to nanometer-scale enables non-invasive administration while preserving the ability to stimulate target cells optically.
2Reliability
If photodiode substrates are used for photovoltaic neuronal stimulation, then cellular activation is achieved, but sub-cellular specificity and ease of administration are reduced
Solution Approach 1:
The patent replaces bulky photodiode substrates with systemically administrable photonic nanoparticles. These nanoparticles can be injected intravenously and will accumulate at target sites, enabling cellular activation without requiring surgical placement of large optical devices. The nanoparticles convert systemically delivered light into localized cellular stimulation.
Solution Approach 2:
The patent segments the photostimulatory function into discrete nanoscale particles that can be distributed systemically. Each nanoparticle acts as an independent photostimulatory unit that can target individual cells or small groups of cells, enabling precise spatial control and easy administration through standard injection routes.
3Reliability
If photothermally-modulating materials are used, then cellular modulation is achieved, but chronic cellular effects due to heat are unknown
Solution Approach 1:
The patent changes the mechanism from photothermal heating to photovoltaic or photomechanical stimulation. The photonic nanoparticles are designed to convert light energy directly into electrical or mechanical signals that activate cell membranes, bypassing the thermal intermediate step. This parameter change from temperature-based to field-based stimulation eliminates concerns about chronic heat damage.
4Measurement precision
If optogenetics is used, then cellular specificity is improved, but genetic modification requirements increase complexity
Solution Approach 1:
The patent introduces photonic nanoparticles as an intermediary that bridges light and cellular membranes without requiring genetic modification. The nanoparticles contain photostimulatory compounds in their structure, acting as external mediators that interact with cell membranes physically rather than requiring internal genetic changes. This achieves cellular specificity through targeted delivery and optical activation without the complexity of viral transduction or CRISPR procedures.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Provides sub-cellular specificity and non-invasive modulation of cellular activity, effectively treating diseases like autoimmune diseases, cancer, and cardiovascular conditions by optically training myocardium to beat at a target frequency.
Implementation Method 1
exposing the interface to light under conditions to depolarize the cell membrane
Data Source
AI summary
This disclosure relates to methods for modulating activity of a cell capable of being activated by light and treating diseases with such methods. The disclosure also provides systems suitable for use in such methods, particularly systems having silicon nanostructures.